MLV: MLV & Co. Reaffirms "Buy" Rating for Omeros (OMER)

Omeros (NASDAQ:OMER)'s stock had its "buy" rating reiterated by MLV & Co. in a report issued on Tuesday, Analyst Ratings.Net reports. They currently have a $38.00 price target on the biopharmaceutical company's stock. MLV & Co.'s target price indicates a potential upside of 81.30% from the stock's previous close. In other Omeros news, Director Thomas [...]